High Tower Advisors, LLC Global X Fds Genomics & Biotec Transaction History

High Tower Advisors, LLC

$64.2 Billion
Q2 2024

A detailed history of High Tower Advisors, LLC transactions in Global X Fds Genomics & Biotec stock. As of the latest transaction made, High Tower Advisors, LLC holds 13,319 shares of GNOM stock, worth $138,251. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,319

Previous 24,038 44.59%

Holding current value

$138,251

Previous $273,000 49.08%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$9.68 - $11.36 $103,759 - $121,767	-10,719 Reduced 44.59%	13,319 $139,000
Q1 2024 May 06, 2024	SELL	$10.75 - $12.29 $54,653 - $62,482	-5,084 Reduced 17.46%	24,038 $273,000
Q4 2023 Feb 12, 2024	BUY	$8.77 - $11.77 $3,630 - $4,872	414 Added 1.44%	29,122 $336,000
Q3 2023 Nov 08, 2023	SELL	$10.07 - $12.5 $70,671 - $87,725	-7,018 Reduced 19.64%	28,708 $291,000
Q2 2023 Aug 14, 2023	SELL	$11.99 - $13.07 $20,610 - $22,467	-1,719 Reduced 4.59%	35,726 $432,000
Q1 2023 May 11, 2023	SELL	$11.73 - $14.18 $318,563 - $385,100	-27,158 Reduced 42.04%	37,445 $461,000
Q4 2022 Feb 08, 2023	SELL	$12.08 - $13.81 $71,718 - $81,989	-5,937 Reduced 8.42%	64,603 $817,000
Q3 2022 Nov 09, 2022	BUY	$12.05 - $16.28 $169,905 - $229,548	14,100 Added 24.98%	70,540 $885,000
Q2 2022 Aug 10, 2022	SELL	$10.66 - $15.9 $63,480 - $94,684	-5,955 Reduced 9.54%	56,440 $690,000
Q1 2022 May 12, 2022	BUY	$13.33 - $19.98 $28,526 - $42,757	2,140 Added 3.55%	62,395 $939,000
Q4 2021 Feb 10, 2022	BUY	$19.42 - $22.42 $845,838 - $976,503	43,555 Added 260.81%	60,255 $1.2 Million
Q3 2021 Nov 12, 2021	BUY	$21.89 - $25.16 $365,563 - $420,172	16,700 New	16,700 $369,000

Others Institutions Holding GNOM

# of Institutions

Shares Held

2.92M

Call Options Held

Put Options Held

200

View Full List

About GLOBAL X FDS GENOMICS & BIOTEC

Ticker GNOM
Sector ETFs
Industry ETFs

More about GNOM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Account

High Tower Advisors, LLC Global X Fds Genomics & Biotec Transaction History